Skip to content

Outside Dhaka delivery charge 130/- advance payable · Cash on delivery all over Bangladesh

Ehavene
Rozy 0.5 mg+0.25 mg Tablet
Rozy 0.5 mg+0.25 mg Tablet
Square Pharmaceuticals PLC

Rozy 0.5 mg+0.25 mg Tablet

Be the first to review SKU: RT-3859
৳420

Women who do not take estrogens or women who change from a continuous combination product may start treatment at any time.

Delivery

Inside Dhaka: 1–2 days · Outside Dhaka: 2–4 days

Cash on Delivery

Pay when you receive your order.

Returns

Easy 7-day return & exchange

Category
Tablet & Capsules
Brand
Square Pharmaceuticals PLC

Product details

Rozy 0.5 mg+0.25 mg Tablet

Hormone replacement therapy (HRT) for the treatment of:

  • Climacteric syndrome in postmenopausal women including vasomotor symptoms (such as hot flushes and sweating attacks), sleep disorders, depressed moods, nervousness and atrophic, urogenital conditions caused by deficient endogenous estrogen production due to natural menopause, hypogonadism, castration or primary ovarian failure in women with an intact uterus.
  • Prevention of postmenopausal osteoporosis.

Pharmacology

173-estradiol, which is chemically and biologically identical to endogenous human E2, and the synthetic progestogen, DRSP. 173-estradiol provides hormone replacement during and after the climacteric. The addition of DRSP helps to provide bleeding control and opposes the development of endometrial hyperplasia caused by estrogens.

Administration

Each pack covers 28 days of treatment. Treatments continuous, which means that the next pack follows immediately without a break. The tablets are to be swallowed whole with some liquid irrespective of food intake.

Side Effects

The most commonly reported adverse drug reactions (ADRs) with Ethinylestradiol & Drospirenone are breast pain, female genital tract bleeding and gastrointestinal and abdominal pains. They occur in >6% of users.

Pregnancy & Lactation

Ethinylestradiol & Drospirenone must not be used during pregnancy and lactation. If pregnancy occurs during medication with Ethinylestradiol & Drospirenone, treatment must be discontinued immediately. Small amounts of DRSP are excreted with the milk.

Overdose Effects

Acute toxicity studies indicate that, even in the case of inadvertent intake of a multiple of the therapeutic dose, no acute toxicity risk is to be expected. In clinical studies up to 100 mg of DRSP and estrogen/ progestogen preparations containing 4 mg E2 were well tolerated.

Therapeutic Class

Drugs for menopausal symptoms: Hormone replacement therapy

Storage Conditions

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

0.0
★★★★★★★★★★

0 reviews

5★ 0
4★ 0
3★ 0
2★ 0
1★ 0

Write a review

⭐

No reviews yet

Bought this product? Share your experience to help others.

You may also like

Recently viewed

Rozy 0.5 mg+0.25 mg Tablet

৳420

Cash on Delivery
07 Days Return
100% Authentic
Support 24/7